|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 37302 |
FusionGeneSummary for TAX1BP3_UBE2G2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: TAX1BP3_UBE2G2 | Fusion gene ID: 37302 | Hgene | Tgene | Gene symbol | TAX1BP3 | UBE2G2 | Gene ID | 30851 | 7327 |
| Gene name | Tax1 binding protein 3 | ubiquitin conjugating enzyme E2 G2 | |
| Synonyms | TIP-1|TIP1 | UBC7 | |
| Cytomap | 17p13.2 | 21q22.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | tax1-binding protein 3Tax interaction protein 1Tax1 (human T-cell leukemia virus type I) binding protein 3glutaminase-interacting protein 3tax-interacting protein 1 | ubiquitin-conjugating enzyme E2 G2E2 ubiquitin-conjugating enzyme G2ubiquitin carrier protein G2ubiquitin conjugating enzyme 7ubiquitin conjugating enzyme G2ubiquitin-conjugating enzyme E2G 2 (UBC7 homolog, yeast)ubiquitin-conjugating enzyme E2G 2 ( | |
| Modification date | 20180519 | 20180523 | |
| UniProtAcc | O14907 | P60604 | |
| Ensembl transtripts involved in fusion gene | ENST00000225525, | ENST00000345496, ENST00000477954, ENST00000330942, | |
| Fusion gene scores | * DoF score | 4 X 5 X 3=60 | 3 X 3 X 2=18 |
| # samples | 4 | 3 | |
| ** MAII score | log2(4/60*10)=-0.584962500721156 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: TAX1BP3 [Title/Abstract] AND UBE2G2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | TAX1BP3 | GO:0007266 | Rho protein signal transduction | 10940294 |
| Hgene | TAX1BP3 | GO:0090630 | activation of GTPase activity | 21139582 |
| Hgene | TAX1BP3 | GO:2000009 | negative regulation of protein localization to cell surface | 16855024 |
| Tgene | UBE2G2 | GO:0044257 | cellular protein catabolic process | 21628527 |
| Tgene | UBE2G2 | GO:0070936 | protein K48-linked ubiquitination | 20061386 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | BC035653 | TAX1BP3 | chr17 | 3570628 | - | UBE2G2 | chr21 | 46189344 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3UTR | ENST00000225525 | ENST00000345496 | TAX1BP3 | chr17 | 3570628 | - | UBE2G2 | chr21 | 46189344 | - |
| intron-intron | ENST00000225525 | ENST00000477954 | TAX1BP3 | chr17 | 3570628 | - | UBE2G2 | chr21 | 46189344 | - |
| intron-intron | ENST00000225525 | ENST00000330942 | TAX1BP3 | chr17 | 3570628 | - | UBE2G2 | chr21 | 46189344 | - |
Top |
FusionProtFeatures for TAX1BP3_UBE2G2 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| TAX1BP3 | UBE2G2 |
| May regulate a number of protein-protein interactions bycompeting for PDZ domain binding sites. Binds CTNNB1 and maythereby act as an inhibitor of the Wnt signaling pathway. Competeswith LIN7A for KCNJ4 binding, and thereby promotes KCNJ4internalization. May play a role in the Rho signaling pathway. Mayplay a role in activation of CDC42 by the viral protein HPV16 E6.{ECO:0000269|PubMed:10940294, ECO:0000269|PubMed:16855024,ECO:0000269|PubMed:21139582}. | Accepts ubiquitin from the E1 complex and catalyzes itscovalent attachment to other proteins. In vitro catalyzes 'Lys-48'-linked polyubiquitination. Involved in endoplasmic reticulum-associated degradation (ERAD). {ECO:0000269|PubMed:20061386,ECO:0000269|PubMed:22607976}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for TAX1BP3_UBE2G2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for TAX1BP3_UBE2G2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for TAX1BP3_UBE2G2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for TAX1BP3_UBE2G2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | TAX1BP3 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|